Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Novan, Inc. (NOVN) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 8-K Completion of Acquisition or Disposition of Assets, Departure of Directors or Certain Officers; Election of Directors; Appoin...
09/27/2023 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits  Interactive Data
09/27/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES BANKRUPTCY COURT DISTRICT OF",
"UNITED STATES BANKRUPTCY COURT DISTRICT OF"
08/24/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financi...
Docs: "AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT",
"OMNIBUS AMENDMENT NO. 1 TO FEE LETTER AND AMENDMENT NO. 2 TO SUPERPRIORITY DEBTOR IN POSSESSION LOAN AND SECURITY AGREEMENT",
"UNITED STATES BANKRUPTCY COURT DISTRICT OF",
"UNITED STATES BANKRUPTCY COURT DISTRICT OF"
07/26/2023 8-K Quarterly results
07/17/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
07/17/2023 8-K Quarterly results
07/06/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
06/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/12/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 4 John A. Donofrio (EVP, COO) has filed a Form 4 on Novan, Inc.
Txns: Granted 85,000 restricted stock units @ $0
06/08/2023 4 GAY JOHN M. (CFO) has filed a Form 4 on Novan, Inc.
Txns: Paid exercise price by delivering 20,669 shares @ $0
Granted 65,000 restricted stock units @ $0
Exercised 65,000 restricted stock units @ $0
Granted 200,000 restricted stock units @ $0
06/08/2023 4 Geer W Kent (Director) has filed a Form 4 on Novan, Inc.
Txns: Granted 103,092 restricted stock units @ $0
Exercised 36,101 restricted stock units @ $0
06/08/2023 4 SANDERS MACHELLE (Director) has filed a Form 4 on Novan, Inc.
Txns: Granted 103,092 restricted stock units @ $0
Exercised 36,101 restricted stock units @ $0
06/08/2023 4 BIERMAN JAMES L (Director) has filed a Form 4 on Novan, Inc.
Txns: Granted 103,092 restricted stock units @ $0
Exercised 36,101 restricted stock units @ $0
06/08/2023 4 KEEGAN ROBERT J (Director) has filed a Form 4 on Novan, Inc.
Txns: Granted 103,092 restricted stock units @ $0
Exercised 36,101 restricted stock units @ $0
06/08/2023 4 Skolsky Steven D (Director) has filed a Form 4 on Novan, Inc.
Txns: Granted 103,092 restricted stock units @ $0
Exercised 36,101 restricted stock units @ $0
05/31/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Novan Focuses Strategic Direction and Announces Restructuring"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 8-K Quarterly results
Docs: "Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update"
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/30/2023 10-K Annual Report for the period ended December 31, 2022
03/30/2023 8-K Quarterly results
03/20/2023 CT ORDER Form CT ORDER - Confidential treatment order:
03/16/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "COMMON STOCK PURCHASE WARRANT NOVAN, INC.",
"PRE-FUNDED COMMON STOCK PURCHASE WARRANT NOVAN, INC.",
"COMMON STOCK PURCHASE WARRANT NOVAN, INC.",
"SMITH, ANDERSON, BLOUNT, DORSETT, MITCHELL & JERNIGAN, L.L.P.",
"SECURITIES PURCHASE AGREEMENT"
03/16/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/15/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/13/2023 8-K Other Events  Interactive Data
03/07/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024",
"N A S D A Q"
01/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum",
"N A S D A Q"
12/21/2022 8-K Quarterly results
12/06/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy